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Summary
The study investigated cardiovascular changes in adult-
onset growth hormone deficiency (GHD) and showed
that patients with adult-onset GHD have a left ventricu-
lar mass index (LVMi) at or below the lower limit of
normal, which improves with one year of growth hor-
mone replacement.
Background
GHD causes cardiovascular problems, with loss of car-
diac response to exercise and increased cardiac mortality,
however the underlying processes are poorly understood.
Methods
Ten patients with adult-onset GHD and age- and sex-
matched controls (n=10) underwent CMR. Patients
underwent scans before disease treatment and at twelve
months after treatment. Cardiac parameters were calcu-
lated and indexed to body surface area (BSA). The com-
parison between groups was done using Mann-U-
Whitney test and within the group using Wilcoxon test.
The data are presented as median values.
Results
Patients with GHD did not have significantly different
left ventricle (LV) mass or volumetric parameters from
controls: LV mass index (LVMi) 55.0 vs. 56.6 g/m
2,
p=0.315; end diastolic volume index (EDVi) 69.2 vs. 76.3
ml/m
2, p=0.1655; end systolic volume index (ESVi) 24.8
vs. 28.3 ml/m
2, p=0.3527 and ejection fraction (EF) 64
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beneath the lower limit of normal when compared to
published normal ranges (55.4 - 74.0 g/m
2).
There were no differences between right ventricular
(RV) EDVi (68.0 vs. 80.8 ml/m
2, p=0.393), ESVi (26.2 vs.
27.5, p=0.7394) and EF (63 vs. 61 %, p=0.9696) in the
GHD group and controls.
Patients with GHD on GH treatment for 1 year showed
an increase in median insulin-like growth factor I (IGF-I)
SDS from -1.83 to +0.40 (p=0.0068). There was no corre-
lation between LVMi and IGF-I SDS (r=0.164, p=0.657).
At one year the median LVMi moved into the previously
published normal range (55.0 to 63.0 g/m
2, normal range
55.4 - 74.0) achieving statistical significance compared to
pre-treatment values (p=0.0156).
Conclusions
Patients with adult-onset GHD have an LVMi at or
below the lower limit of normal, which improves with
one year of growth hormone replacement.
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